Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance to Provide Scrapie Genotyping for Cyprus

NEW YORK, Aug. 23 (GenomeWeb News) - Genaissance Pharmaceuticals will provide scrapie genotyping services to Biotronics of Cyprus, Genaissance said today.


Biotronics has been awarded a contract by the Cypriot government, which derives from a mandate by the European Union for establishing a breeding program in sheep that confers resistance to scrapie.


Under the contract, Genaissance will analyze at least 100,000 samples, collected by Biotronics, over approximately a three-month period.


Earlier this month, Genaissance won a similar contract to provide scrapie genotyping for Greece.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.